Centinel Spine® Launches MIDLINE II-Ti™ in Australia
New York, NY, May 26, 2016 – Centinel Spine, Inc., (Centinel Spine), the pioneer of Stand-Alone, No-Profile®, Integrated Interbody™ fusion devices, launches MIDLINE II-Ti™, a Ti-ACTIVE™ coated, No-Profile, anterior lumbar Integrated Interbody device, in Australia.
“Following the successful MIDLINE II-Ti US launch, we are excited to introduce MIDLINE II-Ti in Australia to complement our STALIF® product offering and bring Ti-ACTIVE to anterior lumbar spinal fusion procedures here,” said John J. Viscogliosi, Chairman & CEO, Centinel Spine.
The MIDLINE II-Ti product family has been available in the United States for just over 9 months with the first clinical implantations by Jessica Shellock, MD, Texas Back Institute®, Plano, TX and James Billys, MD, Florida Orthopaedic Institute®, North Tampa, FL.
MIDLINE II-Ti, the most recent Centinel Spine innovation for anterior lumbar interbody fusion (ALIF) procedures, represents the sixth generation of STALIF technology. MIDLINE II-Ti blends the STALIF Integrated Interbody advantage with Ti-ACTIVE, a uniquely texturized, microporous titanium plasma coating, to form a novel technology and approach to ALIF procedures with 8° to 20° of lordosis, excellent radiographic visualization, three cancellous screws for stability and an optimal fusion environment.
“We first released Ti-ACTIVE on the STALIF C® product family back in 2014. Since then, Ti-ACTIVE is rapidly increasing our STALIF market share.” said Mr. Viscogliosi. He continued, “Ti-ACTIVE is the culmination of over 15 years of titanium coating science, engineering and experience. And, as with all Centinel Spine technology, Ti-ACTIVE has been designed to satisfy the unmet market need to promote fusion in ALIF procedures. There have been over 4,500 Ti-ACTIVE devices successfully implanted to date.”
“I have used STALIF C-Ti™ over the past year and I look forward to incorporating MIDLINE II-Ti™ into my practice,” said Laurence McEntee, MD, Pindara Hospital, Gold Coast. “I believe that MIDLINE II-Ti will offer my lumbar spine surgery patients the benefits of immediate insertion stability, compression at the graft site and an enhanced fusion environment.”
MIDLINE II-Ti is based upon the STALIF MIDLINE II™ product family. MIDLINE II was designed to offer surgeons increased ease of use by reducing the surgical envelope required to implant the device while maintaining the superior biomechanics that have underpinned thirty years of STALIF surgical success. In harmony with Wolff’s law, three strategically configured cancellous screws create additional compression at each treated segment. The Ti-ACTIVE coating increases the contact surface area and friction at the bony endplates. To date, over 1,000 MIDLINE II devices have been implanted.
Richard Laherty, MD, Queensland Neurosurgery and Spine, Australia, states, “I choose to use MIDLINE II as it minimizes my surgical incisions and provides a large graft chamber and up to 20° of lordosis for my anterior lumbar fusion procedures. Adding a titanium coating to this device will also provide clear radiographic visualization and a texturized surface for stability and fusion, which are the ultimate goals of my spine surgery procedures.”
Centinel Spine also develops, manufactures, markets and sells the complete STALIF product family, which includes STALIF C, STALIF C-Ti™ for anterior cervical discectomy fusion (ACDF) procedures and STALIF L™ for lateral lumbar interbody fusion (LLIF) procedures. Recently, Centinel Spine received FDA clearance for ALTOS™ PCT, a posterior cervical stabilization system specifically designed for use in either the cervical lateral masses or cervical-thoracic pedicles.
About Centinel Spine, Inc.
Centinel Spine, Inc. is a privately-held spinal device company leading the development and commercialization of the Stand-Alone, No-Profile, Integrated Interbody fusion technologies. For more information on Centinel Spine products and technologies, please visit the Company’s web site at www.centinelspine.com.
The company began operations in August 2008, through the merger-acquisition of two pioneering medical device companies: Raymedica LLC and Surgicraft LTD. Today, Centinel Spine still embraces the pioneering culture developed at both originating companies and continues its corporate mission of becoming the leading anterior column support spine franchise, providing elegantly simple implants and instruments that are tissue-sparing and generate superior clinical outcomes.
Centinel Spine derived its name from the “Sentinel Sign” – the radiographic confirmation of a successful fusion anterior to the interbody device.
This information in this press release is intended for audiences in Australia.
For more information, please contact:
Centinel Spine, Inc.
900 Airport Road, Suite 3B
West Chester, PA 19380
LBL 216 R01